TY - JOUR AU - Serruys, P. W. AU - Chevalier, B. AU - Sotomi, Y. PY - 2016 DA - 2016// TI - Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)32050-5 DO - 10.1016/S0140-6736(16)32050-5 ID - Serruys2016 ER - TY - STD TI - Ellis SG, Kereiakes DJ, Metzger DC, et al. Everolimus-eluting Bioresorbable scaffolds for coronary artery disease. N Engl J Med. 2015;373(20). ID - ref2 ER - TY - JOUR AU - Wykrzykowska, J. J. AU - Kraak, R. P. AU - Hofma, S. H. PY - 2017 DA - 2017// TI - AIDA investigators. Bioresorbable scaffolds versus metallic stents in routine PCI JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1614954 DO - 10.1056/NEJMoa1614954 ID - Wykrzykowska2017 ER - TY - JOUR AU - Puricel, S. AU - Cuculi, F. AU - Weissner, M. PY - 2016 DA - 2016// TI - Bioresorbable coronary scaffold thrombosis JO - Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors J Am Coll Cardiol VL - 67 ID - Puricel2016 ER - TY - JOUR AU - Kugler, C. AU - Markovic, S. AU - Rottbauer, W. PY - 2017 DA - 2017// TI - Bioresorbable scaffolds compared with everolimus-eluting stents for the treatment of chronic coronary total occlusion: clinical and angiographic results of a matched paired comparison JO - Coron Artery Dis VL - 28 UR - https://doi.org/10.1097/MCA.0000000000000449 DO - 10.1097/MCA.0000000000000449 ID - Kugler2017 ER - TY - JOUR AU - Cortese, B. AU - Ielasi, A. AU - Moscarella, E. PY - 2017 DA - 2017// TI - RAI investigators. Thirty-day outcomes after unrestricted implantation of Bioresorbable vascular scaffold (from the prospective RAI registry) JO - Am J Cardiol VL - 119 UR - https://doi.org/10.1016/j.amjcard.2017.03.017 DO - 10.1016/j.amjcard.2017.03.017 ID - Cortese2017 ER - TY - JOUR AU - Díaz Fernández, J. F. AU - Camacho Freire, S. J. AU - Fernández Guerrero, J. C. PY - 2018 DA - 2018// TI - Everolimus drug-eluting stent performance in patients with long coronary lesions: the multicenter Longprime registry JO - Catheter Cardiovasc Interv VL - 92 UR - https://doi.org/10.1002/ccd.27657 DO - 10.1002/ccd.27657 ID - Díaz Fernández2018 ER - TY - JOUR AU - Lesiak, M. AU - Araszkiewicz, A. AU - Grajek, S. PY - 2016 DA - 2016// TI - Long coronary lesions treated with thin strut Bioresorbable polymer drug eluting stent: experience from multicentre randomized CENTURY II study JO - J Interv Cardiol VL - 29 UR - https://doi.org/10.1111/joic.12262 DO - 10.1111/joic.12262 ID - Lesiak2016 ER - TY - STD TI - Kang DY, Lee CH, Lee PH, et al. Comparison of resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES VI trial. Coron Artery Dis. 2018. https://doi.org/10.1097/MCA.0000000000000680. [Epub ahead of print]. ID - ref9 ER - TY - STD TI - Patra S, Chakraborty RN, Pande A, et al. Zotarolimus-eluting Resolute Integrity versus everolimus-eluting Xience Xpedition stents in the management of very long (>30mm) de novo coronary artery stenosis. Cardiovasc Revasc Med. 2017;18(3):160–164. https://doi.org/10.1016/j.carrev.2016.12.007. Epub 2016 Dec 15. ID - ref10 ER - TY - JOUR AU - Morino, Y. AU - Abe, M. AU - Morimoto, T. PY - 2011 DA - 2011// TI - Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (multicenter CTO registry in Japan) score as a difficulty grading and time assessment tool JO - JACC Cardiovasc Interv. VL - 4 UR - https://doi.org/10.1016/j.jcin.2010.09.024 DO - 10.1016/j.jcin.2010.09.024 ID - Morino2011 ER - TY - JOUR AU - Smith, S. C. AU - Dove, J. T. AU - Jacobs, A. K. PY - 2001 DA - 2001// TI - ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines) - executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guide-lines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the society for cardiac angiography and interventions JO - J Am Coll Cardiol VL - 37 UR - https://doi.org/10.1016/S0735-1097(01)01344-4 DO - 10.1016/S0735-1097(01)01344-4 ID - Smith2001 ER - TY - JOUR AU - Farooq, V. AU - Serruys, P. W. AU - Heo, J. H. PY - 2013 DA - 2013// TI - Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model the potential implications for clinical practice JO - JACC Cardiovasc Interv VL - 6 UR - https://doi.org/10.1016/j.jcin.2012.12.131 DO - 10.1016/j.jcin.2012.12.131 ID - Farooq2013 ER - TY - JOUR AU - Cutlip, D. E. AU - Windecker, S. AU - Mehran, R. PY - 2007 DA - 2007// TI - Academic research consortium. Clinical end points in coronary stent trials: a case for standardized definitions JO - Circulation VL - 115 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.685313 DO - 10.1161/CIRCULATIONAHA.106.685313 ID - Cutlip2007 ER - TY - JOUR AU - Serruys, P. W. AU - Chevalier, B. AU - Dudek, D. PY - 2015 DA - 2015// TI - A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)61455-0 DO - 10.1016/S0140-6736(14)61455-0 ID - Serruys2015 ER - TY - JOUR AU - Gao, R. AU - Yang, Y. AU - Han, Y. PY - 2015 DA - 2015// TI - Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease JO - ABSORB China trial J Am Coll Cardiol VL - 66 UR - https://doi.org/10.1016/j.jacc.2015.09.054 DO - 10.1016/j.jacc.2015.09.054 ID - Gao2015 ER - TY - JOUR AU - Kimura, T. AU - Kozuma, K. AU - Tanabe, K. PY - 2015 DA - 2015// TI - A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan JO - Eur Heart J VL - 36 UR - https://doi.org/10.1093/eurheartj/ehv435 DO - 10.1093/eurheartj/ehv435 ID - Kimura2015 ER - TY - STD TI - Costa JR Jr, Abizaid A, Whitbourn R, ABSORB EXTEND investigators et al. three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: final results of the ABSORB EXTEND trial. Catheter Cardiovasc Interv 2018. https://doi.org/10.1002/ccd.27715. [Epub ahead of print]. ID - ref18 ER - TY - JOUR AU - Capodanno, D. AU - Gori, T. AU - Nef, H. PY - 2015 DA - 2015// TI - Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry JO - EuroIntervention VL - 10 UR - https://doi.org/10.4244/EIJY14M07_11 DO - 10.4244/EIJY14M07_11 ID - Capodanno2015 ER - TY - JOUR AU - Yamaji, K. AU - Räber, L. AU - Windecker, S. PY - 2017 DA - 2017// TI - What determines long-term outcomes using fully bioresorbable scaffolds - the device, the operator or the lesion? JO - EuroIntervention VL - 12 UR - https://doi.org/10.4244/EIJV12I14A277 DO - 10.4244/EIJV12I14A277 ID - Yamaji2017 ER - TY - JOUR AU - Cassese, S. AU - Byrne, R. A. AU - Ndrepepa, G. PY - 2016 DA - 2016// TI - Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)00979-4 DO - 10.1016/S0140-6736(15)00979-4 ID - Cassese2016 ER - TY - JOUR AU - Stone, G. W. AU - Gao, R. AU - Kimura, T. PY - 2016 DA - 2016// TI - 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)01039-9 DO - 10.1016/S0140-6736(15)01039-9 ID - Stone2016 ER - TY - JOUR AU - Lipinski, M. J. AU - Escarcega, R. O. AU - Baker, N. C. PY - 2016 DA - 2016// TI - Scaffold thrombosis after percutaneous coronary intervention with ABSORB Bioresorbable vascular scaffold JO - A Systematic Review and Meta-Analysis JACC Cardiovasc Interv VL - 9 UR - https://doi.org/10.1016/j.jcin.2015.09.024 DO - 10.1016/j.jcin.2015.09.024 ID - Lipinski2016 ER - TY - JOUR AU - Polimeni, A. AU - Weissner, M. AU - Schochlow, K. PY - 2017 DA - 2017// TI - Incidence, clinical presentation, and predictors of clinical restenosis in coronary Bioresorbable scaffolds JO - JACC Cardiovasc Interv. VL - 10 UR - https://doi.org/10.1016/j.jcin.2017.07.034 DO - 10.1016/j.jcin.2017.07.034 ID - Polimeni2017 ER - TY - JOUR AU - Wöhrle, J. AU - Nef, H. M. AU - Naber, C. PY - 2018 DA - 2018// TI - For the GABI-R study group. Predictors of early scaffold thrombosis: results from the multicenter prospective German-Austrian ABSORB RegIstRy JO - Coron Artery Dis VL - 29 UR - https://doi.org/10.1097/MCA.0000000000000618 DO - 10.1097/MCA.0000000000000618 ID - Wöhrle2018 ER - TY - JOUR AU - Tanaka, A. AU - Latib, A. AU - Kawamoto, H. PY - 2017 DA - 2017// TI - Clinical outcomes of a real world cohort following bioresorbable vascular scaffold implantation utilising an optimized implantation strategy JO - EuroIntervention VL - 12 UR - https://doi.org/10.4244/EIJ-D-16-00247 DO - 10.4244/EIJ-D-16-00247 ID - Tanaka2017 ER - TY - JOUR AU - Sotomi, Y. AU - Suwannasom, P. AU - Serruys, P. W. PY - 2017 DA - 2017// TI - Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging JO - EuroIntervention VL - 12 UR - https://doi.org/10.4244/EIJ-D-16-00471 DO - 10.4244/EIJ-D-16-00471 ID - Sotomi2017 ER - TY - JOUR AU - Biscaglia, S. AU - Erriquez, A. AU - Bernucci, D. PY - 2017 DA - 2017// TI - BRS implantation in long lesions requiring device overlapping: myth or reality? JO - J Thorac Dis VL - 9 UR - https://doi.org/10.21037/jtd.2017.06.35 DO - 10.21037/jtd.2017.06.35 ID - Biscaglia2017 ER - TY - JOUR AU - Polimeni, A. AU - Anadol, R. AU - Münzel, T. PY - 2018 DA - 2018// TI - Predictors of bioresorbable scaffold failure in STEMI patients at 3 years follow-up JO - Int J Cardiol VL - 268 UR - https://doi.org/10.1016/j.ijcard.2018.04.081. DO - 10.1016/j.ijcard.2018.04.081. ID - Polimeni2018 ER - TY - JOUR AU - Regazzoli, D. AU - Latib, A. AU - Ezhumalai, B. PY - 2018 DA - 2018// TI - Long-term follow-up of BVS from a prospective multicenter registry: impact of a dedicated implantation technique on clinical outcomes JO - Int J Cardiol VL - 270 UR - https://doi.org/10.1016/j.ijcard.2018.06.094 DO - 10.1016/j.ijcard.2018.06.094 ID - Regazzoli2018 ER - TY - JOUR AU - Anadol, R. AU - Schnitzler, K. AU - Lorenz, L. PY - 2018 DA - 2018// TI - Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds JO - BMC Cardiovasc Disord VL - 18 UR - https://doi.org/10.1186/s12872-018-0811-7. DO - 10.1186/s12872-018-0811-7. ID - Anadol2018 ER - TY - JOUR AU - Haddad, K. AU - Tanguay, J. F. AU - Potter, B. J. PY - 2018 DA - 2018// TI - Longer inflation duration and Predilation-sizing-Postdilation improve Bioresorbable scaffold outcomes in a long-term all-comers Canadian registry JO - Can J Cardiol VL - 34 UR - https://doi.org/10.1016/j.cjca.2018.02.030 DO - 10.1016/j.cjca.2018.02.030 ID - Haddad2018 ER - TY - JOUR AU - Gori, T. AU - Weissner, M. AU - Gönner, S. PY - 2017 DA - 2017// TI - Characteristics, predictors, and mechanisms of thrombosis in coronary Bioresorbable scaffolds JO - Differences Between Early and Late Events JACC Cardiovasc Interv VL - 10 UR - https://doi.org/10.1016/j.jcin.2017.08.020 DO - 10.1016/j.jcin.2017.08.020 ID - Gori2017 ER - TY - JOUR AU - Biscaglia, S. AU - Campo, G. PY - 2017 DA - 2017// TI - Bioresorbable Everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multicenter GHOST-EU (gauging coronary healing with bioresorbable scaffolding plaTforms in EUrope) registry JO - JACC Cardiovasc Interv. VL - 10 UR - https://doi.org/10.1016/j.jcin.2017.04.001. DO - 10.1016/j.jcin.2017.04.001. ID - Biscaglia2017 ER - TY - JOUR AU - Anadol, R. AU - Lorenz, L. AU - Weissner, M. PY - 2018 DA - 2018// TI - Characteristics and outcome of patients with complex coronary lesions treated with bioresorbable scaffolds: three-year follow-up in a cohort of consecutive patients JO - EuroIntervention VL - 14 UR - https://doi.org/10.4244/EIJ-D-17-00410 DO - 10.4244/EIJ-D-17-00410 ID - Anadol2018 ER - TY - JOUR AU - Sorrentino, S. AU - Rosa, S. AU - Ambrosio, G. PY - 2015 DA - 2015// TI - The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment JO - BMC Cardiovasc Disord VL - 15 UR - https://doi.org/10.1186/s12872-015-0163-5 DO - 10.1186/s12872-015-0163-5 ID - Sorrentino2015 ER - TY - JOUR AU - Anadol, R. AU - Dimitriadis, Z. AU - Polimeni, A. PY - 2018 DA - 2018// TI - Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: a three-years follow-up1 JO - Clin Hemorheol Microcirc VL - 69 UR - https://doi.org/10.3233/CH-189101 DO - 10.3233/CH-189101 ID - Anadol2018 ER - TY - JOUR AU - Biscaglia, S. AU - Ugo, F. AU - Ielasi, A. PY - 2016 DA - 2016// TI - Bioresorbable scaffold vs. second generation drug eluting stent in long coronary lesions requiring overlap: a propensity-matched comparison (the UNDERDOGS study) JO - Int J Cardiol VL - 208 UR - https://doi.org/10.1016/j.ijcard.2016.01.202 DO - 10.1016/j.ijcard.2016.01.202 ID - Biscaglia2016 ER - TY - JOUR AU - Wiebe, J. AU - Dörr, O. AU - Liebetrau, C. PY - 2016 DA - 2016// TI - Outcome after long-segment stenting with Everolimus-eluting Bioresorbable scaffolds focusing on the concept of overlapping implantation JO - Rev Esp Cardiol (Engl Ed) VL - 69 UR - https://doi.org/10.1016/j.rec.2016.08.012 DO - 10.1016/j.rec.2016.08.012 ID - Wiebe2016 ER - TY - JOUR AU - Geraci, S. AU - Kawamoto, H. AU - Caramanno, G. PY - 2017 DA - 2017// TI - Et a.. Bioresorbable Everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multicenter GHOST-EU registry JO - JACC Cardiovasc Interv. VL - 10 UR - https://doi.org/10.1016/j.jcin.2016.12.013 DO - 10.1016/j.jcin.2016.12.013 ID - Geraci2017 ER -